Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

7

Revenue 2017

GlaxoSmithKline

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.

GlaxoSmithKline

Pfizer takeover rumour ignites Amarin shares

Pfizer takeover rumour ignites Amarin shares

GlaxoSmithKline paid $5.1bn for Tesaro and its PARP inhibitor Zejula (niraparib) last month, and Eli Lilly snapping up Loxo Oncology for $8bn to claim its just-approved Vikrakvi (larotrectinib) for

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post As Targacept's president and CEO, Hill will need to refocus the firm following the termination last year of its partnership with GlaxoSmithKline – with the loss of a potential $1.5bn

GSK upbeat on its return to oncology market

GSK upbeat on its return to oncology market Zejula signals comeback after four year hiatus. GlaxoSmithKline’s chief executive Emma Walmsley says it can be competitive in oncology in 2019 and beyond, despite having exited the market nearly four

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Previously, Dr. Rickard was vice president Clinical Development and Medical Affairs of GlaxoSmithKline’s Respiratory Medicines Development Centre and, over a period of 15 years, held a number of other leadership ... Rheault started her career as a

First-line ovarian approval cements AZ’s Lynparza lead

First-line ovarian approval cements AZ’s Lynparza lead Tesaro – in the process of being acquired by GlaxoSmithKline – is expecting phase 3 results in the same setting for Zejula next year, while third-to-market Clovis has taken a different

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics